Abstract Background Long noncoding RNAs (lncRNAs) have been reported to play an
important role in tumor immune modification. Nonetheless, the clinical implication of immune …

Background: Renal cell carcinoma (RCC) is the predominant type of malignant tumor in
kidney cancer. Finding effective biomarkers, particularly those based on the tumor immune …

Background: Papillary renal cell carcinoma (pRCC) was the 2 nd most common subtype,
accounting for approximately 15% incidence of renal cell carcinoma (RCC). Immune related …

Kidney renal clear cell carcinoma (KIRC) is the predominant pathological subtype of renal
cell carcinoma (RCC) in adults. Long non-coding RNAs (lncRNAs) are an important class of …

Background Renal cell carcinoma (RCC) is one of the most common aggressive malignant
tumors in urogenital system, and the clear cell renal cell carcinoma (ccRCC) is the most …

Background: Immunogenic cell death (ICD) is an important part of the antitumor effect, yet
the role played by long noncoding RNAs (lncRNAs) remains unclear. We explored the value …

Objective: Using model algorithms, we constructed an immune-related long non-coding
RNAs (lncRNAs) risk coefficient model to predict outcomes for patients with clear cell renal …

Importance Long noncoding RNAs (lncRNAs) are involved in innate and adaptive immunity
in cancer by mediating the functional state of immunologic cells, pathways, and genes …

Introduction The overall survival of patients with high-stage clear cell renal carcinoma
(ccRCC) is poor. However, promising molecular-level prognostic marker is still lacking to …

Background. Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney
cancer whose incidence and mortality rate are increasing. Identifying immune‐related …